Garrison Point Advisors’s Gilead Sciences GILD Stock Holding History

Garrison Point Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$278K	Buy	1,992 +2	+0.1%	+$280	0.13%	144
2025 Q4	$244K	Sell	1,990 -1,698	-46%	-$206K	0.11%	150
2025 Q3	$409K	Buy	3,688 +2	+0.1%	+$227	0.17%	119
2025 Q2	$409K	Sell	3,686 -98	-3%	-$10.4K	0.19%	115
2025 Q1	$424K	Buy	3,784 +2	+0.1%	+$206	0.21%	108
2024 Q4	$349K	Buy	3,782 +2	+0.1%	+$180	0.17%	115
2024 Q3	$317K	Sell	3,780 -108	-3%	-$8.24K	0.2%	114
2024 Q2	$267K	Buy	3,888 +154	+4%	+$10.3K	0.18%	121
2024 Q1	$274K	Buy	3,734 +4	+0.1%	+$308	0.18%	130
2023 Q4	$302K	Buy	3,730 +3	+0.1%	+$233	0.21%	113
2023 Q3	$279K	Buy	3,727 +4	+0.1%	+$308	0.22%	116
2023 Q2	$287K	Buy	3,723 +3	+0.1%	+$239	0.21%	120
2023 Q1	$309K	Buy	+3,720	New	+$308K	0.23%	114

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Garrison Point Advisors's GILD Position: Q1 2026 in Review

Garrison Point Advisors increased its Gilead Sciences (GILD) stake by 0.1% in Q1 2026, buying an estimated $280 and bringing the position to 1,992 shares worth $278K. The position accounts for 0.13% of the portfolio, ranked #144.

Garrison Point Advisors first reported a position in GILD in Q1 2023 and has held it in 13 quarters since. The position peaked at $424K in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Garrison Point Advisors held 1,992 shares of Gilead Sciences worth $278K as of Q1 2026.
Garrison Point Advisors bought 2 Gilead Sciences shares in Q1 2026, an estimated $280.
Gilead Sciences made up 0.13% of Garrison Point Advisors's portfolio in Q1 2026, its #144 holding.
Garrison Point Advisors first reported a position in Gilead Sciences in Q1 2023 and has held it in 13 quarters since.
Garrison Point Advisors's Gilead Sciences position peaked at $424K in Q1 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Garrison Point Advisors's 13F filing for Q1 2026, filed 13 May 2026.